Research project
A Novel Therapeutic Vulnerability in Lung Squamous Cell Carcinoma (LUSC)
- Start date: 1 May 2025
 - End date: 30 April 2027
 - Funder: The Academy of Medical Sciences
 - Value: 159,000.01
 - Primary investigator: Dr Alexander Garvin
 
Project title
A Novel Therapeutic Vulnerability in Lung Squamous Cell Carcinoma (LUSC)